What's in Otsuka Australia Pharmaceutical Pty Ltd's pipeline?

Otsuka Australia Pharmaceutical Pty Ltd has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Otsuka Australia Pharmaceutical Pty Ltd's portfolio?

Top competitors by shared drug class: AbbVie (prior sponsor, Abbott), Assistance Publique - Hôpitaux de Paris, Bio-Path Holdings, Inc., Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias, Race Oncology Ltd.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/otsuka-australia-pharmaceutical-pty-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Otsuka Australia Pharmaceutical Pty Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Otsuka Australia Pharmaceutical Pty Ltd pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Subcutaneous azacitidine	Subcutaneous azacitidine	phase 3	Hypomethylating agent	DNA methyltransferase	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AbbVie (prior sponsor, Abbott) · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Bio-Path Holdings, Inc. · 1 shared drug class
Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias · 1 shared drug class
Race Oncology Ltd · 1 shared drug class
Shirley Ryan AbilityLab · 1 shared drug class
Taiho Oncology, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Otsuka Australia Pharmaceutical Pty Ltd:

Cite this brief

Drug Landscape (2026). Otsuka Australia Pharmaceutical Pty Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/otsuka-australia-pharmaceutical-pty-ltd. Accessed 2026-05-16.